BIOMARKER:

EGFR mutation + EGFR amplification

B | Sensitive

C3 | Sensitive

B | Resistant

C3 | Resistant

Show legend

Drug categories

EGFR

Tyrosine Kinase Inhibitors

Non Small Cell Lung Cancer

Lung Adenocarcinoma

gefitinib

EGFR mutation + EGFR amplification|Non Small Cell Lung Cancer|gefitinib

EGFR inhibitor

EGFR mutation + EGFR amplification|Non Small Cell Lung Cancer|EGFR inhibitor

EGFR mutation + EGFR amplification|Lung Adenocarcinoma|EGFR inhibitor